 | WL7 | Name: | 4-amino-N-(2-hydroxyethyl)-N-methylbenzene-1-sulfonamide | Formula: | C9 H14 N2 O3 S | SMILES: | c1c(ccc(c1)N)S(N(C)CCO)(=O)=O | InChi: | InChI=1S/C9H14N2O3S/c1-11(6-7-12)15(13,14)9-4-2-8(10)3-5-9/h2-5,12H,6-7,10H2,1H3 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 4-amino-N-(2-hydroxyethyl)-N-methylbenzene-1-sulfonamide |
|
 | WLA | Name: | 1-[(oxan-4-yl)methyl]piperazine | Formula: | C10 H20 N2 O | SMILES: | C1CN(CCN1)CC2CCOCC2 | InChi: | InChI=1S/C10H20N2O/c1-7-13-8-2-10(1)9-12-5-3-11-4-6-12/h10-11H,1-9H2 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-[(oxan-4-yl)methyl]piperazine |
|
 | WLD | Name: | (2S)-1-{[(2,6-dichlorophenyl)methyl]amino}propan-2-ol | Formula: | C10 H13 Cl2 N O | SMILES: | c1c(c(c(cc1)Cl)CNCC(C)O)Cl | InChi: | InChI=1S/C10H13Cl2NO/c1-7(14)5-13-6-8-9(11)3-2-4-10(8)12/h2-4,7,13-14H,5-6H2,1H3/t7-/m0/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (2S)-1-{[(2,6-dichlorophenyl)methyl]amino}propan-2-ol |
|
 | WLG | Name: | 1-(5-azaspiro[2.5]octan-5-yl)-2-(difluoromethoxy)ethan-1-one | Formula: | C10 H15 F2 N O2 | SMILES: | C2CN(CC1(CC1)C2)C(COC(F)F)=O | InChi: | InChI=1S/C10H15F2NO2/c11-9(12)15-6-8(14)13-5-1-2-10(7-13)3-4-10/h9H,1-7H2 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-(5-azaspiro[2.5]octan-5-yl)-2-(difluoromethoxy)ethan-1-one |
|
 | WLJ | Name: | (azepan-1-yl)(2,6-difluorophenyl)methanone | Formula: | C13 H15 F2 N O | SMILES: | C1CN(CCCC1)C(c2c(cccc2F)F)=O | InChi: | InChI=1S/C13H15F2NO/c14-10-6-5-7-11(15)12(10)13(17)16-8-3-1-2-4-9-16/h5-7H,1-4,8-9H2 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (azepan-1-yl)(2,6-difluorophenyl)methanone |
|
 | WLS | Name: | 1-(pyridin-4-yl)-N-[(thiophen-2-yl)methyl]methanamine | Formula: | C11 H12 N2 S | SMILES: | c1(cccs1)CNCc2ccncc2 | InChi: | InChI=1S/C11H12N2S/c1-2-11(14-7-1)9-13-8-10-3-5-12-6-4-10/h1-7,13H,8-9H2 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-(pyridin-4-yl)-N-[(thiophen-2-yl)methyl]methanamine |
|
 | WLV | Name: | N-(3-fluorophenyl)-2-phenoxyacetamide | Formula: | C14 H12 F N O2 | SMILES: | C(Oc1ccccc1)C(=O)Nc2cccc(c2)F | InChi: | InChI=1S/C14H12FNO2/c15-11-5-4-6-12(9-11)16-14(17)10-18-13-7-2-1-3-8-13/h1-9H,10H2,(H,16,17) | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | N-(3-fluorophenyl)-2-phenoxyacetamide |
|
 | WM7 | Name: | (3S)-N-benzylpyrrolidin-3-amine | Formula: | C11 H16 N2 | SMILES: | c2cccc(CNC1CCNC1)c2 | InChi: | InChI=1S/C11H16N2/c1-2-4-10(5-3-1)8-13-11-6-7-12-9-11/h1-5,11-13H,6-9H2/t11-/m0/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (3S)-N-benzylpyrrolidin-3-amine |
|
 | WMD | Name: | 1-[(1R)-1-(2-fluorophenyl)ethyl]piperazine | Formula: | C12 H17 F N2 | SMILES: | c2c(C(C)N1CCNCC1)c(ccc2)F | InChi: | InChI=1S/C12H17FN2/c1-10(15-8-6-14-7-9-15)11-4-2-3-5-12(11)13/h2-5,10,14H,6-9H2,1H3/t10-/m1/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-[(1R)-1-(2-fluorophenyl)ethyl]piperazine |
|
 | WMG | Name: | 1-[(1S)-1-(2-fluorophenyl)ethyl]piperazine | Formula: | C12 H17 F N2 | SMILES: | c2c(C(C)N1CCNCC1)c(ccc2)F | InChi: | InChI=1S/C12H17FN2/c1-10(15-8-6-14-7-9-15)11-4-2-3-5-12(11)13/h2-5,10,14H,6-9H2,1H3/t10-/m0/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-[(1S)-1-(2-fluorophenyl)ethyl]piperazine |
|
 | WMS | Name: | 5-fluoro-N-[(2-methyl-1,3-thiazol-5-yl)methyl]pyridin-3-amine | Formula: | C10 H10 F N3 S | SMILES: | Cc1ncc(s1)CNc2cc(cnc2)F | InChi: | InChI=1S/C10H10FN3S/c1-7-13-5-10(15-7)6-14-9-2-8(11)3-12-4-9/h2-5,14H,6H2,1H3 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 5-fluoro-N-[(2-methyl-1,3-thiazol-5-yl)methyl]pyridin-3-amine |
|
 | WMV | Name: | N-(2-cyclohexylethyl)-3,5-dimethyl-1,2-oxazole-4-carboxamide | Formula: | C14 H22 N2 O2 | SMILES: | C2(CCNC(c1c(C)noc1C)=O)CCCCC2 | InChi: | InChI=1S/C14H22N2O2/c1-10-13(11(2)18-16-10)14(17)15-9-8-12-6-4-3-5-7-12/h12H,3-9H2,1-2H3,(H,15,17) | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | N-(2-cyclohexylethyl)-3,5-dimethyl-1,2-oxazole-4-carboxamide |
|
 | WMY | Name: | 3-chloro-N-(1,2-oxazol-3-yl)benzamide | Formula: | C10 H7 Cl N2 O2 | SMILES: | c1onc(c1)NC(c2cccc(c2)Cl)=O | InChi: | InChI=1S/C10H7ClN2O2/c11-8-3-1-2-7(6-8)10(14)12-9-4-5-15-13-9/h1-6H,(H,12,13,14) | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 3-chloro-N-(1,2-oxazol-3-yl)benzamide |
|
 | WNA | Name: | 1-methyl-N-[(2-methylphenyl)methyl]-1H-tetrazol-5-amine | Formula: | C10 H13 N5 | SMILES: | c2(NCc1c(C)cccc1)nnnn2C | InChi: | InChI=1S/C10H13N5/c1-8-5-3-4-6-9(8)7-11-10-12-13-14-15(10)2/h3-6H,7H2,1-2H3,(H,11,12,14) | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-methyl-N-[(2-methylphenyl)methyl]-1H-tetrazol-5-amine |
|
 | WND | Name: | 2-methyl-1-[(oxan-4-yl)amino]propan-2-ol | Formula: | C9 H19 N O2 | SMILES: | CC(C)(CNC1CCOCC1)O | InChi: | InChI=1S/C9H19NO2/c1-9(2,11)7-10-8-3-5-12-6-4-8/h8,10-11H,3-7H2,1-2H3 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 2-methyl-1-[(oxan-4-yl)amino]propan-2-ol |
|
 | WNG | Name: | N-[(Z)-2-phenylethenyl]-1H-benzimidazol-2-amine | Formula: | C15 H13 N3 | SMILES: | c2(nc1c(cccc1)n2)N[C@H]=Cc3ccccc3 | InChi: | InChI=1S/C15H13N3/c1-2-6-12(7-3-1)10-11-16-15-17-13-8-4-5-9-14(13)18-15/h1-11H,(H2,16,17,18)/b11-10- | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | N-[(Z)-2-phenylethenyl]-1H-benzimidazol-2-amine |
|
 | WNJ | Name: | N-{[(3R)-pyrrolidin-3-yl]methyl}pyridin-2-amine | Formula: | C10 H15 N3 | SMILES: | C1CNCC1CNc2ccccn2 | InChi: | InChI=1S/C10H15N3/c1-2-5-12-10(3-1)13-8-9-4-6-11-7-9/h1-3,5,9,11H,4,6-8H2,(H,12,13)/t9-/m1/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | N-{[(3R)-pyrrolidin-3-yl]methyl}pyridin-2-amine |
|
 | WNM | Name: | (3S)-1-(phenylsulfonyl)pyrrolidin-3-amine | Formula: | C10 H14 N2 O2 S | SMILES: | c2(S(N1CCC(N)C1)(=O)=O)ccccc2 | InChi: | InChI=1S/C10H14N2O2S/c11-9-6-7-12(8-9)15(13,14)10-4-2-1-3-5-10/h1-5,9H,6-8,11H2/t9-/m0/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (3S)-1-(phenylsulfonyl)pyrrolidin-3-amine |
|
 | WNP | Name: | N-(3-chlorophenyl)-2,2,2-trifluoroacetamide | Formula: | C8 H5 Cl F3 N O | SMILES: | c1cc(NC(C(F)(F)F)=O)cc(c1)Cl | InChi: | InChI=1S/C8H5ClF3NO/c9-5-2-1-3-6(4-5)13-7(14)8(10,11)12/h1-4H,(H,13,14) | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | N-(3-chlorophenyl)-2,2,2-trifluoroacetamide |
|
 | WNV | Name: | N,N,2,3-tetramethylbenzamide | Formula: | C11 H15 N O | SMILES: | c1(cccc(C(=O)N(C)C)c1C)C | InChi: | InChI=1S/C11H15NO/c1-8-6-5-7-10(9(8)2)11(13)12(3)4/h5-7H,1-4H3 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | N,N,2,3-tetramethylbenzamide |
|
 | WNY | Name: | 1-[4-(4-chlorophenyl)piperazin-1-yl]ethan-1-one | Formula: | C12 H15 Cl N2 O | SMILES: | c2(N1CCN(C(C)=O)CC1)ccc(cc2)Cl | InChi: | InChI=1S/C12H15ClN2O/c1-10(16)14-6-8-15(9-7-14)12-4-2-11(13)3-5-12/h2-5H,6-9H2,1H3 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-[4-(4-chlorophenyl)piperazin-1-yl]ethan-1-one |
|
 | WO1 | Name: | (3R)-1-methylpiperidin-3-yl furan-2-carboxylate | Formula: | C11 H15 N O3 | SMILES: | c2cc(C(=O)OC1CCCN(C)C1)oc2 | InChi: | InChI=1S/C11H15NO3/c1-12-6-2-4-9(8-12)15-11(13)10-5-3-7-14-10/h3,5,7,9H,2,4,6,8H2,1H3/t9-/m1/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (3R)-1-methylpiperidin-3-yl furan-2-carboxylate |
|
 | WO7 | Name: | 1-(1,4-diazepan-1-yl)ethan-1-one | Formula: | C7 H14 N2 O | SMILES: | C1CNCCCN1C(C)=O | InChi: | InChI=1S/C7H14N2O/c1-7(10)9-5-2-3-8-4-6-9/h8H,2-6H2,1H3 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 1-(1,4-diazepan-1-yl)ethan-1-one |
|
 | WOA | Name: | (3S)-3-(methylamino)-1-phenylpiperidin-2-one | Formula: | C12 H16 N2 O | SMILES: | c2(N1CCCC(NC)C1=O)ccccc2 | InChi: | InChI=1S/C12H16N2O/c1-13-11-8-5-9-14(12(11)15)10-6-3-2-4-7-10/h2-4,6-7,11,13H,5,8-9H2,1H3/t11-/m0/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | (3S)-3-(methylamino)-1-phenylpiperidin-2-one |
|
 | WOD | Name: | 3-cyclopropyl-5-[(3R)-pyrrolidin-3-yl]-1,2,4-oxadiazole | Formula: | C9 H13 N3 O | SMILES: | C1C(CNC1)c3onc(C2CC2)n3 | InChi: | InChI=1S/C9H13N3O/c1-2-6(1)8-11-9(13-12-8)7-3-4-10-5-7/h6-7,10H,1-5H2/t7-/m1/s1 | Definition date: | 2020-10-30 | Last modified: | 2020-11-06 | Release date: | 2020-11-11 | Identifier: | 3-cyclopropyl-5-[(3R)-pyrrolidin-3-yl]-1,2,4-oxadiazole |
|